2023
DOI: 10.1089/cbr.2022.0080
|View full text |Cite
|
Sign up to set email alerts
|

Validation of In-House Kit-Like Synthesis of 68Ga-Trivehexin and Its Biodistribution for Targeting the Integrin αvβ6 Expressing Tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…34 The radiopharmaceutical 68 Ga-Trivehexin already proved its clinical potential for imaging of PDAC as well as head-and-neck squamous cell carcinoma (HNSCC). 35…”
Section: Introductionmentioning
confidence: 99%
“…34 The radiopharmaceutical 68 Ga-Trivehexin already proved its clinical potential for imaging of PDAC as well as head-and-neck squamous cell carcinoma (HNSCC). 35…”
Section: Introductionmentioning
confidence: 99%